secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001193125-24-011681
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dianthus Therapeutics raises $230M in PIPE financing at $12.00/share
--------------------------------------------------------------------

- PIPE gross proceeds ~$230M from 14.5M common shares at $12.00 and 4.7M pre-funded warrants at $11.999.
- New and existing investors participating: Bain Capital Life Sciences, RA Capital, Avidity Partners, and others.
- Closing expected Jan 24, 2024; proceeds for R&D, working capital, and potential business development.
- Placement agents: Jefferies, Evercore ISI, Stifel, Guggenheim Securities, Raymond James.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000119312524011681/0001193125-24-011681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000119312524011681/d699582d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-011681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer